The global Antimicrobial Peptides market size was valued at USD 5 million in 2022 and is forecast to a readjusted size of USD 7 million by 2029 with a CAGR of 5.2% during review period.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram-positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019. By region, North America had the highest share of sales, at about 35%.
This report is a detailed and comprehensive analysis for global Antimicrobial Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antimicrobial Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2018-2029
Global Antimicrobial Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2018-2029
Global Antimicrobial Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2018-2029
Global Antimicrobial Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Mg), and ASP (US$/Mg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antimicrobial Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antimicrobial Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Pharmaceuticals
Feed Additives
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Antimicrobial peptides (AMPs) exhibit broad-spectrum antimicrobial activity, making them effective against various pathogens, including bacteria, fungi, and viruses.
- Increasing resistance to traditional antibiotics enhances the demand for AMPs as alternative therapeutic agents, driving market growth.
Weaknesses:
- High production costs and complexity associated with the synthesis and purification of AMPs may limit their widespread adoption.
- Limited understanding of the mechanisms of action and potential toxicity of AMPs raises concerns about their safety and efficacy.
Opportunities:
- Growing investment in research and development for novel AMP-based therapies presents opportunities for innovation and market expansion.
- The rising prevalence of antibiotic-resistant infections provides a significant market opportunity for AMPs as potential solutions to combat resistance.
Threats:
- Regulatory challenges and lengthy approval processes for new AMP therapies may hinder timely market entry and product availability.
- Competition from alternative antimicrobial agents, such as phage therapy and traditional antibiotics, poses a threat to the market share of AMPs.
Political:
- Government initiatives and funding for antimicrobial resistance (AMR) research and development could drive the growth of the AMP market.
- Regulatory policies regarding the approval of new antimicrobial therapies may impact the speed of market penetration for AMP-based treatments.
Economic:
- Rising healthcare costs and the burden of drug-resistant infections create a growing economic demand for cost-effective AMP solutions.
- The high cost of production for AMPs could limit their affordability and accessibility, especially in low-income regions.
Social:
- Increasing awareness of antimicrobial resistance among the public and healthcare providers could drive demand for alternative therapies like AMPs.
- Social acceptance of AMP-based treatments is influenced by perceptions of their safety and efficacy compared to traditional antibiotics.
Technological:
- Advancements in biotechnology and peptide synthesis technologies could lower production costs and improve the scalability of AMPs.
- Innovations in delivery systems for AMPs may enhance their therapeutic effectiveness and broaden their application in treating infections.
Environmental:
- The sustainable production of AMPs, using green chemistry techniques, could appeal to environmentally conscious consumers and stakeholders.
- Environmental concerns related to the disposal and degradation of AMP-based treatments may require effective solutions to minimize ecological impact.
Legal:
- Intellectual property rights related to AMP formulations and patents could drive innovation, but also create market competition among manufacturers.
- Strict regulatory requirements for clinical trials and approval processes may delay the availability of AMP-based therapies.
Suppliers:
- Biotech companies and pharmaceutical manufacturers involved in the research and development of antimicrobial peptides (AMPs).
- Raw material suppliers of amino acids, peptides, and other necessary compounds for AMP synthesis and formulation.
Inputs:
- Advanced biotechnology and peptide synthesis technologies to develop effective AMPs.
- Clinical trial data and research findings on the efficacy and safety of AMPs for various infections.
Processes:
- Research and development processes focused on identifying and optimizing AMPs with broad-spectrum activity.
- Manufacturing processes involving the synthesis, purification, and formulation of AMPs for commercial use.
Outputs:
- Commercialized antimicrobial peptides used for the treatment of bacterial, fungal, and viral infections.
- Regulatory approval of AMP-based therapies and products available for healthcare providers.
Customers:
- Healthcare providers and hospitals seeking alternative treatments for drug-resistant infections.
- Pharmaceutical companies, researchers, and healthcare organizations looking for innovative solutions to combat antimicrobial resistance.
Threat of New Entrants:
- High capital investment and expertise in biotechnology and peptide synthesis create a barrier to entry for new players in the AMP market.
- Strong regulatory requirements and lengthy approval processes for new antimicrobial therapies could deter potential new entrants.
Bargaining Power of Suppliers:
- The limited number of specialized suppliers for raw materials (amino acids, peptides) gives them significant bargaining power in pricing and availability.
- Suppliers with advanced technologies in peptide synthesis and production hold a strong position in determining costs and scalability for AMP manufacturers.
Bargaining Power of Buyers:
- Healthcare providers and pharmaceutical companies have significant bargaining power due to the availability of alternative antimicrobial therapies.
- The increasing demand for cost-effective treatments for antimicrobial resistance pressures AMP producers to offer competitive pricing.
Threat of Substitute Products:
- Traditional antibiotics and alternative therapies, such as phage therapy, pose a significant threat as substitutes to antimicrobial peptides.
- The development of new and effective antimicrobial agents could limit the adoption of AMPs in the healthcare market.
Industry Rivalry:
- The increasing number of companies developing AMPs and other alternative therapies heightens competition within the antimicrobial market.
- Ongoing innovation and advancements in AMP technologies may lead to price competition, driving down profit margins for existing manufacturers.
Raw Materials:
- The supply of amino acids and peptides, critical for the synthesis of antimicrobial peptides, is controlled by a few specialized suppliers, affecting the cost and availability.
- The increasing demand for high-quality, pure raw materials could drive up the cost of production for antimicrobial peptides.
Technology and R&D:
- Advancements in peptide synthesis technologies and bioengineering are essential for enhancing the production efficiency and scalability of antimicrobial peptides.
- Investment in research and development is required to discover new peptides with broader antimicrobial activity and improved safety profiles.
Regulatory Environment:
- Strict regulations governing the approval of novel therapeutic peptides create a lengthy and costly process for AMP developers.
- Government policies and funding for antimicrobial resistance research can help accelerate the development of AMPs by supporting innovation and regulatory pathways.
Manufacturing and Production:
- The complexity of AMP synthesis and purification processes requires specialized facilities and skilled labor, which can increase production costs.
- Advances in manufacturing technologies, such as automated peptide synthesis and scalable production systems, are needed to meet growing market demand at competitive prices.
Distribution and Supply Chain:
- The distribution network for antimicrobial peptides is still developing, and building efficient logistics channels for global delivery could improve market reach.
- Cold chain storage requirements and stability concerns for peptide-based therapies may complicate the supply chain, requiring specialized infrastructure.
Market Demand and Adoption:
- Rising concerns about antibiotic resistance are driving demand for alternative antimicrobial solutions, increasing the adoption of antimicrobial peptides in clinical settings.
- The effectiveness of antimicrobial peptides in treating multidrug-resistant infections could expand their use in hospitals, research, and specialized healthcare markets.
Customer Segments:
- Healthcare providers, particularly in hospitals and clinics, are the primary customers for AMP-based treatments, especially for drug-resistant infections.
- Pharmaceutical companies and research institutions are significant customers, focusing on developing new AMP-based therapeutics and clinical applications.
Chapter 1, to describe Antimicrobial Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antimicrobial Peptides, with price, sales, revenue and global market share of Antimicrobial Peptides from 2018 to 2023.
Chapter 3, the Antimicrobial Peptides competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antimicrobial Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antimicrobial Peptides market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antimicrobial Peptides.
Chapter 14 and 15, to describe Antimicrobial Peptides sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Antimicrobial Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antimicrobial Peptides Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Plant Antimicrobial Peptides
1.3.3 Microbial Antimicrobial Peptides
1.3.4 Animal Antimicrobial Peptides
1.4 Market Analysis by Application
1.4.1 Overview: Global Antimicrobial Peptides Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceuticals
1.4.3 Feed Additives
1.4.4 Others
1.5 Global Antimicrobial Peptides Market Size & Forecast
1.5.1 Global Antimicrobial Peptides Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Antimicrobial Peptides Sales Quantity (2018-2029)
1.5.3 Global Antimicrobial Peptides Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AnaSpec
2.1.1 AnaSpec Details
2.1.2 AnaSpec Major Business
2.1.3 AnaSpec Antimicrobial Peptides Product and Services
2.1.4 AnaSpec Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AnaSpec Recent Developments/Updates
2.2 AMP Biotech
2.2.1 AMP Biotech Details
2.2.2 AMP Biotech Major Business
2.2.3 AMP Biotech Antimicrobial Peptides Product and Services
2.2.4 AMP Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AMP Biotech Recent Developments/Updates
2.3 Phoenix Biotech
2.3.1 Phoenix Biotech Details
2.3.2 Phoenix Biotech Major Business
2.3.3 Phoenix Biotech Antimicrobial Peptides Product and Services
2.3.4 Phoenix Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Phoenix Biotech Recent Developments/Updates
2.4 Novabiotics
2.4.1 Novabiotics Details
2.4.2 Novabiotics Major Business
2.4.3 Novabiotics Antimicrobial Peptides Product and Services
2.4.4 Novabiotics Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novabiotics Recent Developments/Updates
2.5 Chinese Peptide
2.5.1 Chinese Peptide Details
2.5.2 Chinese Peptide Major Business
2.5.3 Chinese Peptide Antimicrobial Peptides Product and Services
2.5.4 Chinese Peptide Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Chinese Peptide Recent Developments/Updates
2.6 Ontores
2.6.1 Ontores Details
2.6.2 Ontores Major Business
2.6.3 Ontores Antimicrobial Peptides Product and Services
2.6.4 Ontores Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ontores Recent Developments/Updates
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Antimicrobial Peptides Product and Services
2.7.4 GenScript Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GenScript Recent Developments/Updates
2.8 Hycult Biotech
2.8.1 Hycult Biotech Details
2.8.2 Hycult Biotech Major Business
2.8.3 Hycult Biotech Antimicrobial Peptides Product and Services
2.8.4 Hycult Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hycult Biotech Recent Developments/Updates
2.9 Sunsmile
2.9.1 Sunsmile Details
2.9.2 Sunsmile Major Business
2.9.3 Sunsmile Antimicrobial Peptides Product and Services
2.9.4 Sunsmile Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sunsmile Recent Developments/Updates
2.10 Ruixing Biotechnology
2.10.1 Ruixing Biotechnology Details
2.10.2 Ruixing Biotechnology Major Business
2.10.3 Ruixing Biotechnology Antimicrobial Peptides Product and Services
2.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ruixing Biotechnology Recent Developments/Updates
2.11 Zhongnong Yingtai Biotechnology
2.11.1 Zhongnong Yingtai Biotechnology Details
2.11.2 Zhongnong Yingtai Biotechnology Major Business
2.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product and Services
2.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhongnong Yingtai Biotechnology Recent Developments/Updates
2.12 Glam Technology
2.12.1 Glam Technology Details
2.12.2 Glam Technology Major Business
2.12.3 Glam Technology Antimicrobial Peptides Product and Services
2.12.4 Glam Technology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Glam Technology Recent Developments/Updates
2.13 ProteLight Pharmaceutical & Biotechnology
2.13.1 ProteLight Pharmaceutical & Biotechnology Details
2.13.2 ProteLight Pharmaceutical & Biotechnology Major Business
2.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product and Services
2.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
3 Competitive Environment: Antimicrobial Peptides by Manufacturer
3.1 Global Antimicrobial Peptides Sales Quantity by Manufacturer (2018-2023)
3.2 Global Antimicrobial Peptides Revenue by Manufacturer (2018-2023)
3.3 Global Antimicrobial Peptides Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Antimicrobial Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Antimicrobial Peptides Manufacturer Market Share in 2022
3.4.2 Top 6 Antimicrobial Peptides Manufacturer Market Share in 2022
3.5 Antimicrobial Peptides Market: Overall Company Footprint Analysis
3.5.1 Antimicrobial Peptides Market: Region Footprint
3.5.2 Antimicrobial Peptides Market: Company Product Type Footprint
3.5.3 Antimicrobial Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Antimicrobial Peptides Market Size by Region
4.1.1 Global Antimicrobial Peptides Sales Quantity by Region (2018-2029)
4.1.2 Global Antimicrobial Peptides Consumption Value by Region (2018-2029)
4.1.3 Global Antimicrobial Peptides Average Price by Region (2018-2029)
4.2 North America Antimicrobial Peptides Consumption Value (2018-2029)
4.3 Europe Antimicrobial Peptides Consumption Value (2018-2029)
4.4 Asia-Pacific Antimicrobial Peptides Consumption Value (2018-2029)
4.5 South America Antimicrobial Peptides Consumption Value (2018-2029)
4.6 Middle East and Africa Antimicrobial Peptides Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Antimicrobial Peptides Sales Quantity by Type (2018-2029)
5.2 Global Antimicrobial Peptides Consumption Value by Type (2018-2029)
5.3 Global Antimicrobial Peptides Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Antimicrobial Peptides Sales Quantity by Application (2018-2029)
6.2 Global Antimicrobial Peptides Consumption Value by Application (2018-2029)
6.3 Global Antimicrobial Peptides Average Price by Application (2018-2029)
7 North America
7.1 North America Antimicrobial Peptides Sales Quantity by Type (2018-2029)
7.2 North America Antimicrobial Peptides Sales Quantity by Application (2018-2029)
7.3 North America Antimicrobial Peptides Market Size by Country
7.3.1 North America Antimicrobial Peptides Sales Quantity by Country (2018-2029)
7.3.2 North America Antimicrobial Peptides Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Antimicrobial Peptides Sales Quantity by Type (2018-2029)
8.2 Europe Antimicrobial Peptides Sales Quantity by Application (2018-2029)
8.3 Europe Antimicrobial Peptides Market Size by Country
8.3.1 Europe Antimicrobial Peptides Sales Quantity by Country (2018-2029)
8.3.2 Europe Antimicrobial Peptides Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Antimicrobial Peptides Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Antimicrobial Peptides Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Antimicrobial Peptides Market Size by Region
9.3.1 Asia-Pacific Antimicrobial Peptides Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Antimicrobial Peptides Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Antimicrobial Peptides Sales Quantity by Type (2018-2029)
10.2 South America Antimicrobial Peptides Sales Quantity by Application (2018-2029)
10.3 South America Antimicrobial Peptides Market Size by Country
10.3.1 South America Antimicrobial Peptides Sales Quantity by Country (2018-2029)
10.3.2 South America Antimicrobial Peptides Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Antimicrobial Peptides Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Antimicrobial Peptides Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Antimicrobial Peptides Market Size by Country
11.3.1 Middle East & Africa Antimicrobial Peptides Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Antimicrobial Peptides Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Antimicrobial Peptides Market Drivers
12.2 Antimicrobial Peptides Market Restraints
12.3 Antimicrobial Peptides Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Antimicrobial Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antimicrobial Peptides
13.3 Antimicrobial Peptides Production Process
13.4 Antimicrobial Peptides Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antimicrobial Peptides Typical Distributors
14.3 Antimicrobial Peptides Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Antimicrobial Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antimicrobial Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AnaSpec Basic Information, Manufacturing Base and Competitors
Table 4. AnaSpec Major Business
Table 5. AnaSpec Antimicrobial Peptides Product and Services
Table 6. AnaSpec Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AnaSpec Recent Developments/Updates
Table 8. AMP Biotech Basic Information, Manufacturing Base and Competitors
Table 9. AMP Biotech Major Business
Table 10. AMP Biotech Antimicrobial Peptides Product and Services
Table 11. AMP Biotech Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AMP Biotech Recent Developments/Updates
Table 13. Phoenix Biotech Basic Information, Manufacturing Base and Competitors
Table 14. Phoenix Biotech Major Business
Table 15. Phoenix Biotech Antimicrobial Peptides Product and Services
Table 16. Phoenix Biotech Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Phoenix Biotech Recent Developments/Updates
Table 18. Novabiotics Basic Information, Manufacturing Base and Competitors
Table 19. Novabiotics Major Business
Table 20. Novabiotics Antimicrobial Peptides Product and Services
Table 21. Novabiotics Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novabiotics Recent Developments/Updates
Table 23. Chinese Peptide Basic Information, Manufacturing Base and Competitors
Table 24. Chinese Peptide Major Business
Table 25. Chinese Peptide Antimicrobial Peptides Product and Services
Table 26. Chinese Peptide Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Chinese Peptide Recent Developments/Updates
Table 28. Ontores Basic Information, Manufacturing Base and Competitors
Table 29. Ontores Major Business
Table 30. Ontores Antimicrobial Peptides Product and Services
Table 31. Ontores Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ontores Recent Developments/Updates
Table 33. GenScript Basic Information, Manufacturing Base and Competitors
Table 34. GenScript Major Business
Table 35. GenScript Antimicrobial Peptides Product and Services
Table 36. GenScript Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. GenScript Recent Developments/Updates
Table 38. Hycult Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Hycult Biotech Major Business
Table 40. Hycult Biotech Antimicrobial Peptides Product and Services
Table 41. Hycult Biotech Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hycult Biotech Recent Developments/Updates
Table 43. Sunsmile Basic Information, Manufacturing Base and Competitors
Table 44. Sunsmile Major Business
Table 45. Sunsmile Antimicrobial Peptides Product and Services
Table 46. Sunsmile Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sunsmile Recent Developments/Updates
Table 48. Ruixing Biotechnology Basic Information, Manufacturing Base and Competitors
Table 49. Ruixing Biotechnology Major Business
Table 50. Ruixing Biotechnology Antimicrobial Peptides Product and Services
Table 51. Ruixing Biotechnology Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ruixing Biotechnology Recent Developments/Updates
Table 53. Zhongnong Yingtai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. Zhongnong Yingtai Biotechnology Major Business
Table 55. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product and Services
Table 56. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zhongnong Yingtai Biotechnology Recent Developments/Updates
Table 58. Glam Technology Basic Information, Manufacturing Base and Competitors
Table 59. Glam Technology Major Business
Table 60. Glam Technology Antimicrobial Peptides Product and Services
Table 61. Glam Technology Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Glam Technology Recent Developments/Updates
Table 63. ProteLight Pharmaceutical & Biotechnology Basic Information, Manufacturing Base and Competitors
Table 64. ProteLight Pharmaceutical & Biotechnology Major Business
Table 65. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product and Services
Table 66. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Quantity (Mg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
Table 68. Global Antimicrobial Peptides Sales Quantity by Manufacturer (2018-2023) & (Mg)
Table 69. Global Antimicrobial Peptides Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Antimicrobial Peptides Average Price by Manufacturer (2018-2023) & (US$/Mg)
Table 71. Market Position of Manufacturers in Antimicrobial Peptides, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Antimicrobial Peptides Production Site of Key Manufacturer
Table 73. Antimicrobial Peptides Market: Company Product Type Footprint
Table 74. Antimicrobial Peptides Market: Company Product Application Footprint
Table 75. Antimicrobial Peptides New Market Entrants and Barriers to Market Entry
Table 76. Antimicrobial Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Antimicrobial Peptides Sales Quantity by Region (2018-2023) & (Mg)
Table 78. Global Antimicrobial Peptides Sales Quantity by Region (2024-2029) & (Mg)
Table 79. Global Antimicrobial Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Antimicrobial Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Antimicrobial Peptides Average Price by Region (2018-2023) & (US$/Mg)
Table 82. Global Antimicrobial Peptides Average Price by Region (2024-2029) & (US$/Mg)
Table 83. Global Antimicrobial Peptides Sales Quantity by Type (2018-2023) & (Mg)
Table 84. Global Antimicrobial Peptides Sales Quantity by Type (2024-2029) & (Mg)
Table 85. Global Antimicrobial Peptides Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Antimicrobial Peptides Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Antimicrobial Peptides Average Price by Type (2018-2023) & (US$/Mg)
Table 88. Global Antimicrobial Peptides Average Price by Type (2024-2029) & (US$/Mg)
Table 89. Global Antimicrobial Peptides Sales Quantity by Application (2018-2023) & (Mg)
Table 90. Global Antimicrobial Peptides Sales Quantity by Application (2024-2029) & (Mg)
Table 91. Global Antimicrobial Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Antimicrobial Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Antimicrobial Peptides Average Price by Application (2018-2023) & (US$/Mg)
Table 94. Global Antimicrobial Peptides Average Price by Application (2024-2029) & (US$/Mg)
Table 95. North America Antimicrobial Peptides Sales Quantity by Type (2018-2023) & (Mg)
Table 96. North America Antimicrobial Peptides Sales Quantity by Type (2024-2029) & (Mg)
Table 97. North America Antimicrobial Peptides Sales Quantity by Application (2018-2023) & (Mg)
Table 98. North America Antimicrobial Peptides Sales Quantity by Application (2024-2029) & (Mg)
Table 99. North America Antimicrobial Peptides Sales Quantity by Country (2018-2023) & (Mg)
Table 100. North America Antimicrobial Peptides Sales Quantity by Country (2024-2029) & (Mg)
Table 101. North America Antimicrobial Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Antimicrobial Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Antimicrobial Peptides Sales Quantity by Type (2018-2023) & (Mg)
Table 104. Europe Antimicrobial Peptides Sales Quantity by Type (2024-2029) & (Mg)
Table 105. Europe Antimicrobial Peptides Sales Quantity by Application (2018-2023) & (Mg)
Table 106. Europe Antimicrobial Peptides Sales Quantity by Application (2024-2029) & (Mg)
Table 107. Europe Antimicrobial Peptides Sales Quantity by Country (2018-2023) & (Mg)
Table 108. Europe Antimicrobial Peptides Sales Quantity by Country (2024-2029) & (Mg)
Table 109. Europe Antimicrobial Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Antimicrobial Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Antimicrobial Peptides Sales Quantity by Type (2018-2023) & (Mg)
Table 112. Asia-Pacific Antimicrobial Peptides Sales Quantity by Type (2024-2029) & (Mg)
Table 113. Asia-Pacific Antimicrobial Peptides Sales Quantity by Application (2018-2023) & (Mg)
Table 114. Asia-Pacific Antimicrobial Peptides Sales Quantity by Application (2024-2029) & (Mg)
Table 115. Asia-Pacific Antimicrobial Peptides Sales Quantity by Region (2018-2023) & (Mg)
Table 116. Asia-Pacific Antimicrobial Peptides Sales Quantity by Region (2024-2029) & (Mg)
Table 117. Asia-Pacific Antimicrobial Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Antimicrobial Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Antimicrobial Peptides Sales Quantity by Type (2018-2023) & (Mg)
Table 120. South America Antimicrobial Peptides Sales Quantity by Type (2024-2029) & (Mg)
Table 121. South America Antimicrobial Peptides Sales Quantity by Application (2018-2023) & (Mg)
Table 122. South America Antimicrobial Peptides Sales Quantity by Application (2024-2029) & (Mg)
Table 123. South America Antimicrobial Peptides Sales Quantity by Country (2018-2023) & (Mg)
Table 124. South America Antimicrobial Peptides Sales Quantity by Country (2024-2029) & (Mg)
Table 125. South America Antimicrobial Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Antimicrobial Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Antimicrobial Peptides Sales Quantity by Type (2018-2023) & (Mg)
Table 128. Middle East & Africa Antimicrobial Peptides Sales Quantity by Type (2024-2029) & (Mg)
Table 129. Middle East & Africa Antimicrobial Peptides Sales Quantity by Application (2018-2023) & (Mg)
Table 130. Middle East & Africa Antimicrobial Peptides Sales Quantity by Application (2024-2029) & (Mg)
Table 131. Middle East & Africa Antimicrobial Peptides Sales Quantity by Region (2018-2023) & (Mg)
Table 132. Middle East & Africa Antimicrobial Peptides Sales Quantity by Region (2024-2029) & (Mg)
Table 133. Middle East & Africa Antimicrobial Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Antimicrobial Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Antimicrobial Peptides Raw Material
Table 136. Key Manufacturers of Antimicrobial Peptides Raw Materials
Table 137. Antimicrobial Peptides Typical Distributors
Table 138. Antimicrobial Peptides Typical Customers
List of Figures
Figure 1. Antimicrobial Peptides Picture
Figure 2. Global Antimicrobial Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antimicrobial Peptides Consumption Value Market Share by Type in 2022
Figure 4. Plant Antimicrobial Peptides Examples
Figure 5. Microbial Antimicrobial Peptides Examples
Figure 6. Animal Antimicrobial Peptides Examples
Figure 7. Global Antimicrobial Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Antimicrobial Peptides Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceuticals Examples
Figure 10. Feed Additives Examples
Figure 11. Others Examples
Figure 12. Global Antimicrobial Peptides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Antimicrobial Peptides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Antimicrobial Peptides Sales Quantity (2018-2029) & (Mg)
Figure 15. Global Antimicrobial Peptides Average Price (2018-2029) & (US$/Mg)
Figure 16. Global Antimicrobial Peptides Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Antimicrobial Peptides Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Antimicrobial Peptides by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Antimicrobial Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Antimicrobial Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Antimicrobial Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Antimicrobial Peptides Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Antimicrobial Peptides Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Antimicrobial Peptides Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Antimicrobial Peptides Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Antimicrobial Peptides Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Antimicrobial Peptides Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Antimicrobial Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Antimicrobial Peptides Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Antimicrobial Peptides Average Price by Type (2018-2029) & (US$/Mg)
Figure 31. Global Antimicrobial Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Antimicrobial Peptides Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Antimicrobial Peptides Average Price by Application (2018-2029) & (US$/Mg)
Figure 34. North America Antimicrobial Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Antimicrobial Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Antimicrobial Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Antimicrobial Peptides Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Antimicrobial Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Antimicrobial Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Antimicrobial Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Antimicrobial Peptides Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Antimicrobial Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Antimicrobial Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Antimicrobial Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Antimicrobial Peptides Consumption Value Market Share by Region (2018-2029)
Figure 54. China Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Antimicrobial Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Antimicrobial Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Antimicrobial Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Antimicrobial Peptides Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Antimicrobial Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Antimicrobial Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Antimicrobial Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Antimicrobial Peptides Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Antimicrobial Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Antimicrobial Peptides Market Drivers
Figure 75. Antimicrobial Peptides Market Restraints
Figure 76. Antimicrobial Peptides Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Antimicrobial Peptides in 2022
Figure 79. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 80. Antimicrobial Peptides Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
